Status:
COMPLETED
The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Gastrointestinal Motility Disorder
Dyspepsia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Functional Dyspepsia-Postprandial Distress Syndrome (FD-PDS), is characterized by meal-related symptoms such as early satiation and postprandial fullness. Disturbances of gastric motor function have b...
Eligibility Criteria
Inclusion
- Healthy volunteers, male and females, between 18-60 years old
Exclusion
- Subjects that:
- They are older than 60 years old.
- Have severely decreased kidney function.
- Have severely decreased liver function.
- Have severe heart disease, for example a history of irregular heartbeats, angina or heart attack.
- Have severe lung disease.
- Have severe psychiatric illness or neurological illness.
- Have any gastrointestinal disease
- Women that are pregnant or breastfeeding.
- Have a rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption (Resolor tablets contain lactose).
Key Trial Info
Start Date :
September 26 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2016
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04429802
Start Date
September 26 2013
End Date
October 3 2016
Last Update
October 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.